share_log

Bristol Myers Squibb Announces Opdivo plus Chemotherapy Demonstrated A Statistically Significant And Clinically Meaningful Benefit For The Primary And Secondary Endpoints Of Overall Survival; Co. Repo

Bristol Myers Squibb Announces Opdivo plus Chemotherapy Demonstrated A Statistically Significant And Clinically Meaningful Benefit For The Primary And Secondary Endpoints Of Overall Survival; Co. Repo

百時美施貴寶公司宣佈Opdivo加化療顯示出對總存活率的主要和次要終點有統計意義和臨牀意義的益處；Repo公司
Benzinga Real-time News ·  2021/04/08 19:00

Bristol Myers Squibb Announces Opdivo plus Chemotherapy Demonstrated A Statistically Significant And Clinically Meaningful Benefit For The Primary And Secondary Endpoints Of Overall Survival; Co. Reports Opdivo Plus Yervoy Also Met Its Primary Endpoint

百時美施貴寶公司宣佈Opdivo Plus化療顯示出對總存活率的主要和次要終點有統計意義和臨牀意義的益處；公司報告Opdivo Plus Yervoy也滿足其主要終點

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論